Purpose

The aim of this study is to evaluate the efficacy of a brief psychoeducational intervention to improve the self-efficacy of patients with locally advanced rectal cancer who are initiating multimodality treatment (e.g., total neoadjuvant therapy).

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Ageā‰„18 years 2. Within 4 weeks after documented decision to pursue multi-modality therapy for newly diagnosed LARC (i.e., stage II or III disease) 3. Able to complete study procedures English or with the assistance of an interpreter

Exclusion Criteria

  1. Comorbid health condition that would interfere with study participation, as identified by cancer care team 2. Has undergone treatment for a prior colorectal cancer

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
Participants will be randomized to either the intervention or enhanced usual care. Randomization will be stratified by treatment sequence (e.g., chemotherapy first vs. concurrent chemoradiation first).
Primary Purpose
Supportive Care
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Study Phase I: PATHWAYS Intervention
Participants assigned to the PATHWAYS Intervention will receive: 1) four coaching sessions, 2) a comprehensive patient education guidebook, and 3) a coaching session workbook.
  • Behavioral: PATHWAYS
    The PATHWAYS intervention is a psychoeducational intervention comprised of three components.
Active Comparator
Study Phase I: Enhanced Usual Care
Participants assigned to the enhanced usual care will receive: 1) an information resource guide for navigating information online.
  • Other: Enhanced usual care
    The enhanced usual care condition consists of an information resource guide.
Experimental
Study Phase II: PATHWAYS Intervention
Participants assigned to the PATHWAYS Intervention will receive: 1) four coaching sessions, 2) a comprehensive patient education guidebook, and 3) a coaching session workbook.
  • Behavioral: PATHWAYS
    The PATHWAYS intervention is a psychoeducational intervention comprised of three components.
Active Comparator
Study Phase II: Enhanced Usual Care
Participants assigned to the enhanced usual care will receive: 1) an information resource guide for navigating information online.
  • Other: Enhanced usual care
    The enhanced usual care condition consists of an information resource guide.

Recruiting Locations

Massachusetts General Hospital
Boston, Massachusetts 02114
Contact:
Kelsey Lau-Min, MD, MSCE
617-724-4000
klau-min@mgh.harvard.edu

More Details

Status
Recruiting
Sponsor
Massachusetts General Hospital

Study Contact

Kelsey Lau-Min, MD, MSCE
617-724-4000
klau-min@mgh.harvard.edu

Detailed Description

This is a randomized control trial that will be split into two phases. Study Phase I will test the feasibility and acceptability of a study evaluating a psychoeducational intervention relative to a control condition for improving self-efficacy in patients with locally advanced rectal cancer who are initiating multimodality treatment. It is expected that this phase will enroll 20 participants. Study Phase II will test the efficacy of the psychoeducational intervention after it has been refined using findings from Study Phase I. It is expected this phase will enroll 100 participants. In this study, participants will complete survey questions and will be randomly assigned to either receive the intervention (consisting of 4 coaching sessions with a study clinician, a comprehensive patient education guidebook, and a coaching session workbook) or enhanced usual care (consisting of an information resource guide for navigating information online). It is expected that about 120 people will take part in this research study.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.